{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:06:17Z","timestamp":1789985177786,"version":"4.0.1"},"reference-count":178,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.autrev.2014.08.032","type":"journal-article","created":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T14:16:52Z","timestamp":1409149012000},"page":"1149-1159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":139,"title":["Adult onset Still's disease (AOSD) in the era of biologic therapies: Dichotomous view for cytokine and clinical expressions"],"prefix":"10.1016","volume":"13","author":[{"given":"Alexandre Thibault Jacques","family":"Maria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Le Quellec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Jorgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Touitou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Rivi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Guilpain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.autrev.2014.08.032_bb0005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/ard.30.2.121","article-title":"Still's disease in the adult","volume":"30","author":"Bywaters","year":"1971","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2014.08.032_bb0010","article-title":"On a form of chronic joint disease in children","volume":"80","author":"Still","year":"1897","journal-title":"Med Chir Trans"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.032_bb0015","first-page":"424","article-title":"Preliminary criteria for classification of adult Still's disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2014.08.032_bb0020","first-page":"748","article-title":"Adult Still's disease: part I. Manifestations and complications in sixty-five cases in France","volume":"62","author":"Masson","year":"1995","journal-title":"Rev Rhum Engl Ed"},{"issue":"6","key":"10.1016\/j.autrev.2014.08.032_bb0025","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0002-9343(80)90201-6","article-title":"Adult Still's disease","volume":"68","author":"Esdaile","year":"1980","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.032_bb0030","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/art.1780300209","article-title":"Adult-onset Still's disease. Clinical course and outcome","volume":"30","author":"Cush","year":"1987","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.08.032_bb0035","series-title":"M\u00e9decine\/Sciences F","first-page":"449","article-title":"Maladie de Still de l'adulte","volume":"vol. 1","author":"Pouchot","year":"2008"},{"issue":"4","key":"10.1016\/j.autrev.2014.08.032_bb0040","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0002-9343(99)80318-0","article-title":"A controlled study of the long-term prognosis of adult Still's disease","volume":"98","author":"Sampalis","year":"1995","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.032_bb0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MD.0000000000000021","article-title":"Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients","volume":"93","author":"Gerfaud-Valentin","year":"2014","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.032_bb0050","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","article-title":"Adult Still's disease: manifestations, disease course, and outcome in 62 patients","volume":"70","author":"Pouchot","year":"1991","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.032_bb0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0049-0172(87)90015-1","article-title":"Adult onset Still's disease: experience in 23 patients and literature review with emphasis on organ failure","volume":"17","author":"Reginato","year":"1987","journal-title":"Semin Arthritis Rheum"},{"issue":"235","key":"10.1016\/j.autrev.2014.08.032_bb0060","first-page":"1055","article-title":"Adult-onset Still's disease; clinical and laboratory features, treatment and progress of 45 cases","volume":"61","author":"Wouters","year":"1986","journal-title":"Q J Med"},{"issue":"6","key":"10.1016\/j.autrev.2014.08.032_bb0065","first-page":"1139","article-title":"Adult Still's disease: review of 228 cases from the literature","volume":"14","author":"Ohta","year":"1987","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2014.08.032_bb0070","first-page":"1058","article-title":"Adult Still's disease: a multicenter survey of Japanese patients","volume":"17","author":"Ohta","year":"1990","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2014.08.032_bb0075","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/ard.54.7.587","article-title":"Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France","volume":"54","author":"Magadur-Joly","year":"1995","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.032_bb0080","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0950-3579(05)80283-3","article-title":"Adult-onset Still's disease","volume":"5","author":"van de Putte","year":"1991","journal-title":"Baillieres Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2014.08.032_bb0085","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2188\/jea.7.221","article-title":"Estimated prevalence and incidence of adult Still's disease: findings by a nationwide epidemiological survey in Japan","volume":"7","author":"Wakai","year":"1997","journal-title":"J Epidemiol"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.032_bb0090","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/art.1780190216","article-title":"Carpal arthritis with ankylosis in late onset Still's disease","volume":"19","author":"Medsger","year":"1976","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.032_bb0095","first-page":"592","article-title":"Severe sore throat as a presenting symptom of adult onset Still's disease: a case series and review of the literature","volume":"24","author":"Nguyen","year":"1997","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.032_bb0100","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/BF02207972","article-title":"Cerebral involvement in adult onset Still's disease","volume":"11","author":"Bruckle","year":"1992","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2014.08.032_bb0105","first-page":"698","article-title":"Meningoencephalitis and peripheral neuropathy complicating adult Still's disease","volume":"17","author":"Denault","year":"1990","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.032_bb0110","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/BF02231592","article-title":"Interstitial lung disease and adult-onset Still's disease","volume":"12","author":"Van Hoeyweghen","year":"1993","journal-title":"Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2014.08.032_bb0115","doi-asserted-by":"crossref","first-page":"812","DOI":"10.2169\/internalmedicine.31.812","article-title":"Adult Still's disease with myocarditis and peritonitis","volume":"31","author":"Hosaka","year":"1992","journal-title":"Intern Med"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.032_bb0120","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0167-5273(90)90295-G","article-title":"Myocarditis in adult Still's disease","volume":"27","author":"Sachs","year":"1990","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.032_bb0125","first-page":"78","article-title":"Non-infectious mitral endocarditis during Still's disease in adults. A case with histologic study of the endocardium","volume":"141","author":"Taillan","year":"1990","journal-title":"Ann Med Interne (Paris)"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.032_bb0130","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00296-008-0619-3","article-title":"Etanercept as a rescue agent in patient with adult onset Still's disease complicated with congestive heart failure","volume":"29","author":"Yang","year":"2008","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.032_bb0135","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3346\/jkms.2004.19.1.137","article-title":"Adult-onset Still's disease with disseminated intravascular coagulation and multiple organ dysfunctions dramatically treated with cyclosporine A","volume":"19","author":"Park","year":"2004","journal-title":"J Korean Med Sci"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.032_bb0140","first-page":"385","article-title":"Thrombotic thrombocytopenic purpura in adult Still's disease","volume":"23","author":"Boki","year":"1996","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2014.08.032_bb0145","first-page":"253","article-title":"Hemolytic uremic syndrome\/thrombotic thrombocytopenic purpura (HUS\/TTP) complicating adult Still's disease: remission induced with intravenous immunoglobulin G","volume":"10","author":"Diamond","year":"1997","journal-title":"J Nephrol"},{"issue":"7","key":"10.1016\/j.autrev.2014.08.032_bb0150","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.amjmed.2003.04.001","article-title":"Resolution with etanercept of nephrotic syndrome due to renal AA amyloidosis in adult Still's disease","volume":"115","author":"Serratrice","year":"2003","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.autrev.2014.08.032_bb0155","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/ard.50.4.257","article-title":"Adult onset Still's disease and related renal amyloidosis","volume":"50","author":"Wendling","year":"1991","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.autrev.2014.08.032_bb0160","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s10067-006-0440-x","article-title":"Ten years of clinical experience with adult onset Still's disease: is the outcome improving?","volume":"26","author":"Uppal","year":"2007","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2014.08.032_bb0165","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/art.11368","article-title":"Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review","volume":"49","author":"Dhote","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.032_bb0170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/MD.0b013e3181caf100","article-title":"Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features and long-term outcome: a case\u2013control study of 8 patients","volume":"89","author":"Hot","year":"2010","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"10.1016\/j.autrev.2014.08.032_bb0175","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1136\/ard.2005.046904","article-title":"Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature","volume":"65","author":"Arlet","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.032_bb0180","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00296-009-1204-0","article-title":"A rare trigger for macrophage activation syndrome","volume":"31","author":"Agarwal","year":"2011","journal-title":"Rheumatol Int"},{"issue":"6","key":"10.1016\/j.autrev.2014.08.032_bb0185","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jbspin.2013.04.011","article-title":"Reactive macrophage activation syndrome possibly triggered by canakinumab in a patient with adult-onset Still's disease","volume":"80","author":"Banse","year":"2013","journal-title":"Joint Bone Spine"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.032_bb0190","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3109\/s10165-010-0348-9","article-title":"Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome","volume":"21","author":"Kobayashi","year":"2011","journal-title":"Mod Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2014.08.032_bb0195","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1136\/ard.2008.098335","article-title":"Diagnostic value of procalcitonin for differentiation between bacterial infection and non-infectious inflammation in febrile patients with active adult-onset Still's disease","volume":"68","author":"Chen","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.032_bb0200","first-page":"322","article-title":"Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease","volume":"28","author":"Fautrel","year":"2001","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.032_bb0205","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/rheumatology\/30.2.158","article-title":"Ferritin and adult Still's disease","volume":"30","author":"Olive","year":"1991","journal-title":"Br J Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2014.08.032_bb0210","first-page":"1425","article-title":"Hyperferritinemia in adult onset Still's disease and the hemophagocytic syndrome","volume":"19","author":"Coffernils","year":"1992","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2014.08.032_bb0215","first-page":"890","article-title":"Serum ferritin and isoferritins are tools for diagnosis of active adult Still's disease","volume":"21","author":"Van Reeth","year":"1994","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2014.08.032_bb0220","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.autrev.2007.01.016","article-title":"Ferritin in autoimmune diseases","volume":"6","author":"Zandman-Goddard","year":"2007","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2014.08.032_bb0225","first-page":"1027","article-title":"High ferritin and low glycosylated ferritin may also be a marker of excessive macrophage activation","volume":"30","author":"Lambotte","year":"2003","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2014.08.032_bb0230","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/ard.59.5.347","article-title":"Percentage of glycosylated serum ferritin remains low throughout the course of adult onset Still's disease","volume":"59","author":"Vignes","year":"2000","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.032_bb0235","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00005792-200205000-00003","article-title":"Proposal for a new set of classification criteria for adult-onset still disease","volume":"81","author":"Fautrel","year":"2002","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.032_bb0240","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1568-9972(03)00091-0","article-title":"Pathogenesis of hemophagocytic syndrome (HPS)","volume":"3","author":"Larroche","year":"2004","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.032_bb0245","first-page":"495","article-title":"Comparative study of 6 types of criteria in adult Still's disease","volume":"23","author":"Masson","year":"1996","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2014.08.032_bb0250","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3899\/jrheum.100766","article-title":"Evaluation of clinical measures and different criteria for diagnosis of adult-onset Still's disease in a Chinese population","volume":"38","author":"Jiang","year":"2011","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.032_bb0255","first-page":"349","article-title":"Characterization of lymph node histology in adult onset Still's disease","volume":"16","author":"Valente","year":"1989","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.032_bb0260","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00296-012-2377-5","article-title":"Does searching for antineutrophil cytoplasmic antibodies help with the diagnosis of Adult-onset Still's disease?","volume":"33","author":"Saghafi","year":"2013","journal-title":"Rheumatol Int"},{"issue":"9","key":"10.1016\/j.autrev.2014.08.032_bb0265","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/rheumatology\/ken288","article-title":"Ankylosing spondylitis and spondylarthropathy presenting with a clinical picture of adult onset Still's disease: case series","volume":"47","author":"Akkoc","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.autrev.2014.08.032_bb0270","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3109\/03009749709065695","article-title":"Serological findings in patients with acute syndromes fulfilling the proposed criteria of adult onset Still's disease","volume":"26","author":"Valtonen","year":"1997","journal-title":"Scand J Rheumatol"},{"issue":"10","key":"10.1016\/j.autrev.2014.08.032_bb0275","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/oxfordjournals.eurheartj.a060756","article-title":"Atypical presentation of adult Still's disease mimicking acute bacterial endocarditis","volume":"16","author":"Zenagui","year":"1995","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.autrev.2014.08.032_bb0280","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/ard.47.9.764","article-title":"Adult onset Still's disease and viral infections","volume":"47","author":"Wouters","year":"1988","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.032_bb0285","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/08916939309010646","article-title":"Aberrant cellular localization of rubella viral genome in patients with adult Still's disease\u2014a pilot study","volume":"16","author":"Newkirk","year":"1993","journal-title":"Autoimmunity"},{"issue":"8855","key":"10.1016\/j.autrev.2014.08.032_bb0290","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/0140-6736(93)91184-N","article-title":"Adult Still's disease associated with acute human parvovirus B19 infection","volume":"341","author":"Pouchot","year":"1993","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.autrev.2014.08.032_bb0295","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0002-9343(02)01238-X","article-title":"Human herpesvirus 6 and adult-onset Still's disease","volume":"113","author":"Daibata","year":"2002","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.autrev.2014.08.032_bb0300","first-page":"1792","article-title":"Hepatitis A infection mimicking adult onset Still's disease","volume":"27","author":"Sridharan","year":"2000","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.032_bb0305","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/BF02208701","article-title":"Adult-onset Still's disease associated to toxoplasma gondii infection","volume":"10","author":"Balleari","year":"1991","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.032_bb0310","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10067-009-1305-x","article-title":"Adult onset Still's disease diagnosed concomitantly with occult papillary thyroid cancer: paraneoplastic manifestation or coincidence?","volume":"29","author":"Ahn","year":"2010","journal-title":"Clin Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2014.08.032_bb0315","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/1097-0142(19950401)75:7<1608::AID-CNCR2820750709>3.0.CO;2-A","article-title":"Metastatic breast cancer presenting as fever, rash, and arthritis","volume":"75","author":"Drenth","year":"1995","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.autrev.2014.08.032_bb0320","first-page":"1786","article-title":"Breast cancer with systemic manifestations mimicking Still's disease","volume":"20","author":"Rogues","year":"1993","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.autrev.2014.08.032_bb0325","first-page":"1788","article-title":"Immunoblastic malignant lymphoma in adult onset Still's disease","volume":"20","author":"Trotta","year":"1993","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.032_bb0330","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.revmed.2013.02.014","article-title":"Adult-onset Still's disease as a manifestation of malignancy: report of a patient with melanoma and literature review","volume":"35","author":"Liozon","year":"2014","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.autrev.2014.08.032_bb0335","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1741-7015-11-185","article-title":"The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome","volume":"11","author":"Rosario","year":"2013","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.032_bb0340","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jbspin.2008.05.009","article-title":"Is Still's disease an autoinflammatory syndrome?","volume":"76","author":"Hayem","year":"2009","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.autrev.2014.08.032_bb0345","doi-asserted-by":"crossref","first-page":"480373","DOI":"10.1155\/2012\/480373","article-title":"Is Still's disease an autoinflammatory syndrome?","volume":"2012","author":"Rossi-Semerano","year":"2012","journal-title":"Int J Inflamm"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.032_bb0350","first-page":"559","article-title":"Evaluation of revised International League of Associations for Rheumatology classification criteria for juvenile idiopathic arthritis in Spanish children (Edmonton 2001)","volume":"32","author":"Merino","year":"2005","journal-title":"J Rheumatol"},{"issue":"9783","key":"10.1016\/j.autrev.2014.08.032_bb0355","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0140-6736(11)60244-4","article-title":"Juvenile idiopathic arthritis","volume":"377","author":"Prakken","year":"2011","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.autrev.2014.08.032_bb0360","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.autrev.2011.02.001","article-title":"The pathogenesis of oligoarticular\/polyarticular vs systemic juvenile idiopathic arthritis","volume":"10","author":"Lin","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.autrev.2014.08.032_bb0365","first-page":"2189","article-title":"Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease","volume":"31","author":"Chen","year":"2004","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2014.08.032_bb0370","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/rheumatology\/40.12.1398","article-title":"Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease","volume":"40","author":"Fujii","year":"2001","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.032_bb0375","first-page":"41","article-title":"Adult onset Still's disease: clinical presentation in a large cohort of Italian patients","volume":"28","author":"Franchini","year":"2010","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2014.08.032_bb0380","first-page":"4","article-title":"Clinical manifestations of adult-onset Still's disease presenting with erosive arthritis: association with low levels of ferritin and interleukin-18","volume":"66","author":"Ichida","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2014.08.032_bb0385","doi-asserted-by":"crossref","first-page":"981232","DOI":"10.1155\/2013\/981232","article-title":"Adult onset Still's disease: a case report with a rare clinical manifestation and pathophysiological correlations","volume":"2013","author":"Antoniou","year":"2013","journal-title":"Case Rep Med"},{"key":"10.1016\/j.autrev.2014.08.032_bb0390","doi-asserted-by":"crossref","first-page":"964751","DOI":"10.1155\/2012\/964751","article-title":"Adult onset Still's disease and autoinflammation","volume":"2012","author":"Efthimiou","year":"2012","journal-title":"Int J Inflamm"},{"issue":"9","key":"10.1016\/j.autrev.2014.08.032_bb0395","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.revmed.2006.05.003","article-title":"Evolution and prognosis of adult onset Still's disease. A monocentric study of 17 patients","volume":"27","author":"Fraisse","year":"2006","journal-title":"Rev Med Interne"},{"issue":"4","key":"10.1016\/j.autrev.2014.08.032_bb0400","first-page":"784","article-title":"Fulminant hepatic failure in adult onset Still's disease","volume":"23","author":"Dino","year":"1996","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.032_bb0405","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2169\/internalmedicine1962.30.247","article-title":"Adult-onset Still's disease: hepatic involvement and various serum markers relating to the disease activity","volume":"30","author":"Motoo","year":"1991","journal-title":"Jpn J Med"},{"issue":"11","key":"10.1016\/j.autrev.2014.08.032_bb0410","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00296-008-0813-3","article-title":"Fatal myocarditis in adult-onset Still disease with diffuse intravascular coagulation","volume":"29","author":"Colina","year":"2009","journal-title":"Rheumatol Int"},{"issue":"5","key":"10.1016\/j.autrev.2014.08.032_bb0415","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ajh.21084","article-title":"Retinal microangiopathy and rapidly fatal cerebral edema in a patient with adult-onset Still's disease and concurrent macrophage activation syndrome","volume":"83","author":"Gianella","year":"2008","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1016\/j.autrev.2014.08.032_bb0420","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1002\/art.27532","article-title":"Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still's disease","volume":"62","author":"Franchini","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.autrev.2014.08.032_bb0425","first-page":"2422","article-title":"Serum cytokine profiles in patients with adult onset Still's disease","volume":"30","author":"Choi","year":"2003","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2014.08.032_bb0430","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1002\/art.38398","article-title":"Efficacy of tocilizumab in conventional treatment-refractory adult-onset still's disease: multicenter retrospective open-label study of thirty-four patients","volume":"66","author":"Ortiz-Sanjuan","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2014.08.032_bb0435","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.berh.2012.07.002","article-title":"Biological treatment in adult-onset Still's disease","volume":"26","author":"Pouchot","year":"2012","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.032_bb0440","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.semarthrit.2007.04.002","article-title":"Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature","volume":"37","author":"Kotter","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.08.032_bb0445","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.25.022106.141627","article-title":"Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*)","volume":"27","author":"Masters","year":"2009","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.032_bb0450","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3109\/03009742.2013.824023","article-title":"Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still's disease","volume":"43","author":"Jung","year":"2014","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.032_bb0455","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.clim.2004.03.023","article-title":"Adult Still's disease reflects a Th2 rather than a Th1 cytokine profile","volume":"112","author":"Saiki","year":"2004","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.032_bb0460","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1186\/ar4193","article-title":"Involvement of TLR7 MyD88-dependent signaling pathway in the pathogenesis of adult-onset Still's disease","volume":"15","author":"Chen","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.032_bb0465","first-page":"396","article-title":"Elevated serum interleukin 6, interferon-gamma, and tumor necrosis factor-alpha levels in patients with adult Still's disease","volume":"25","author":"Hoshino","year":"1998","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2014.08.032_bb0470","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/rheumatology\/38.5.477","article-title":"High serum level of macrophage-colony stimulating factor (M-CSF) in adult-onset Still's disease","volume":"38","author":"Matsui","year":"1999","journal-title":"Rheumatology (Oxford)"},{"issue":"49","key":"10.1016\/j.autrev.2014.08.032_bb0475","first-page":"192","article-title":"Retrospective monocentric study of 17 patients with adult Still's disease, with special focus on liver abnormalities","volume":"50","author":"Andres","year":"2003","journal-title":"Hepatogastroenterology"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.032_bb0480","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/03009740310000148","article-title":"Bone marrow findings in patients with adult Still's disease","volume":"32","author":"Min","year":"2003","journal-title":"Scand J Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2014.08.032_bb0485","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","article-title":"Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade","volume":"201","author":"Pascual","year":"2005","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.032_bb0490","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1517\/13543784.17.3.349","article-title":"The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis","volume":"17","author":"Kalliolias","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"issue":"6","key":"10.1016\/j.autrev.2014.08.032_bb0495","first-page":"653","article-title":"Interleukin 6: a possible marker of disease activity in adult onset Still's disease","volume":"14","author":"Scheinberg","year":"1996","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2014.08.032_bb0500","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/ncprheum0338","article-title":"Interleukin 6: from bench to bedside","volume":"2","author":"Nishimoto","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.032_bb0505","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1053\/jhep.2003.50318","article-title":"Massive liver growth in mice induced by systemic interleukin 6 administration","volume":"38","author":"Zimmers","year":"2003","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.032_bb0510","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/BOR.0b013e3283295fec","article-title":"Clinical value of blocking IL-6 receptor","volume":"21","author":"Mima","year":"2009","journal-title":"Curr Opin Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2014.08.032_bb0515","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1002\/1529-0131(200107)44:7<1716::AID-ART298>3.0.CO;2-I","article-title":"Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still's disease","volume":"44","author":"Kawaguchi","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.032_bb0520","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/1529-0131(200103)44:3<550::AID-ANR103>3.0.CO;2-5","article-title":"Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease","volume":"44","author":"Kawashima","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2014.08.032_bb0525","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3899\/jrheum.130575","article-title":"Interleukin 18: a biomarker for differential diagnosis between adult-onset Still's disease and sepsis","volume":"41","author":"Priori","year":"2014","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2014.08.032_bb0530","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/ard.2003.016428","article-title":"Synovial tissue interleukin-18 expression and the response to treatment in patients with inflammatory arthritis","volume":"63","author":"Rooney","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2014.08.032_bb0535","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.autrev.2006.08.010","article-title":"Interleukin-18 in chronic joint diseases","volume":"6","author":"Lotito","year":"2007","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.032_bb0540","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/ard.2008.093781","article-title":"Lymph node IL-18 expression in adult-onset Still's disease","volume":"68","author":"Conigliaro","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2014.08.032_bb0545","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/rheumatology\/keq397","article-title":"Markedly increased IL-18 liver expression in adult-onset Still's disease-related hepatitis","volume":"50","author":"Priori","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.autrev.2014.08.032_bb0550","first-page":"1093","article-title":"Interleukin 18 and hepatocyte growth factor in fulminant hepatic failure of adult onset Still's disease","volume":"30","author":"Ogata","year":"2003","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2014.08.032_bb0555","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/sj.gene.6363922","article-title":"Association between adult-onset Still's disease and interleukin-18 gene polymorphisms","volume":"3","author":"Sugiura","year":"2002","journal-title":"Genes Immun"},{"issue":"5","key":"10.1016\/j.autrev.2014.08.032_bb0560","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3899\/jrheum.090662","article-title":"Cytokine profiles of macrophage activation syndrome associated with rheumatic diseases","volume":"37","author":"Maruyama","year":"2010","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2014.08.032_bb0565","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2169\/internalmedicine.51.6678","article-title":"Interleukin-18 in adult-onset Still's disease: treatment target or disease activity indicator?","volume":"51","author":"Nagashima","year":"2012","journal-title":"Intern Med"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.032_bb0570","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1074-7613(00)80111-9","article-title":"Caspase-1-independent, Fas\/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice","volume":"11","author":"Tsutsui","year":"1999","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.autrev.2014.08.032_bb0575","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.3899\/jrheum.100247","article-title":"Clinical manifestations but not cytokine profiles differentiate adult-onset Still's disease and sepsis","volume":"37","author":"Rau","year":"2010","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.032_bb0580","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2165\/00003495-200868030-00005","article-title":"Adult-onset Still's disease: pathogenesis, clinical manifestations and therapeutic advances","volume":"68","author":"Kontzias","year":"2008","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.autrev.2014.08.032_bb0585","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1345\/aph.1E425","article-title":"Leflunomide and azathioprine combination in refractory adult-onset Still's disease","volume":"39","author":"Cefle","year":"2005","journal-title":"Ann Pharmacother"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.032_bb0590","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10067-002-0667-0","article-title":"Treatment of adult-onset Still's disease with leflunomide and chloroquine combination in two patients","volume":"22","author":"Pirildar","year":"2003","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.032_bb0595","first-page":"373","article-title":"Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease","volume":"26","author":"Fautrel","year":"1999","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2014.08.032_bb0600","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0248-8663(96)80703-X","article-title":"Treatment of Still disease in adults with intravenous immunoglobulins","volume":"16","author":"Permal","year":"1995","journal-title":"Rev Med Interne"},{"issue":"Suppl. 4","key":"10.1016\/j.autrev.2014.08.032_bb0605","doi-asserted-by":"crossref","first-page":"419s","DOI":"10.1016\/S0248-8663(00)88672-5","article-title":"Still's disease in adults: treatment with intravenous immunoglobulins","volume":"20","author":"Vignes","year":"1999","journal-title":"Rev Med Interne"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.032_bb0610","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/rheumatology\/ket250","article-title":"Biologic treatments for adult-onset Still's disease","volume":"53","author":"Al-Homood","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.032_bb0615","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/ard.2004.024026","article-title":"Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases","volume":"64","author":"Fautrel","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.autrev.2014.08.032_bb0620","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/art.10231","article-title":"Etanercept in the treatment of adult patients with Still's disease","volume":"46","author":"Husni","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.032_bb0625","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/RHU.0b013e318205092d","article-title":"Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids","volume":"17","author":"Bruck","year":"2011","journal-title":"J Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.032_bb0630","doi-asserted-by":"crossref","first-page":"R91","DOI":"10.1186\/ar3366","article-title":"Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study","volume":"13","author":"Laskari","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.032_bb0635","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/ard.2007.076034","article-title":"Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France","volume":"67","author":"Lequerre","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.autrev.2014.08.032_bb0640","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.3899\/jrheum.111549","article-title":"Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still's disease. An open, randomized, multicenter study","volume":"39","author":"Nordstrom","year":"2012","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2014.08.032_bb0645","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jbspin.2013.12.011","article-title":"Canakinumab in a case of Adult onset Still's disease: efficacy only on systemic manifestations","volume":"81","author":"Lo Gullo AC","year":"2014","journal-title":"Joint Bone Spine"},{"issue":"5","key":"10.1016\/j.autrev.2014.08.032_bb0650","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3109\/s10165-011-0569-6","article-title":"Therapeutic response of patients with adult Still's disease to biologic agents: multicenter results in Japan","volume":"22","author":"Suematsu","year":"2012","journal-title":"Mod Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.032_bb0655","first-page":"23","article-title":"Infliximab (anti-TNF-alpha) treatment in patients with adult Still's disease. Experience in 2 cases","volume":"21","author":"Bonilla Hernan","year":"2004","journal-title":"An Med Interna"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.032_bb0660","first-page":"113","article-title":"A case of adult onset Still's disease treated with infliximab","volume":"20","author":"Caramaschi","year":"2002","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2014.08.032_bb0665","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.rhu.0000135618.25723.16","article-title":"Treatment of resistant adult still disease with infliximab: a report of 2 cases","volume":"10","author":"Huffstutter","year":"2004","journal-title":"J Clin Rheumatol"},{"issue":"4\u20135","key":"10.1016\/j.autrev.2014.08.032_bb0670","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10067-003-0744-z","article-title":"Infliximab in a case of early adult-onset Still's disease","volume":"22","author":"Olivieri","year":"2003","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.032_bb0675","first-page":"329","article-title":"Infliximab in the treatment of adult Still's disease refractory to conventional therapy","volume":"19","author":"Cavagna","year":"2001","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.032_bb0680","first-page":"121","article-title":"Prolonged efficacy of infliximab for refractory adult-onset Still's disease","volume":"23","author":"Dilhuydy","year":"2005","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.032_bb0685","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10067-003-0775-5","article-title":"Successful treatment of refractory adult-onset Still's disease with infliximab. A prospective, non-comparative series of four patients","volume":"23","author":"Kokkinos","year":"2004","journal-title":"Clin Rheumatol"},{"issue":"Suppl. 3","key":"10.1016\/j.autrev.2014.08.032_bb0690","doi-asserted-by":"crossref","first-page":"iii55","DOI":"10.1136\/ard.60.90003.iii55","article-title":"Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences","volume":"60","author":"Kraetsch","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"29\u201330","key":"10.1016\/j.autrev.2014.08.032_bb0695","first-page":"414","article-title":"Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders","volume":"132","author":"Aeberli","year":"2002","journal-title":"Swiss Med Wkly"},{"issue":"5","key":"10.1016\/j.autrev.2014.08.032_bb0700","first-page":"733","article-title":"Adalimumab (anti-TNF-alpha) therapy to improve the clinical course of adult-onset Still's disease: the first case report","volume":"23","author":"Benucci","year":"2005","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.032_bb0705","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s10067-004-1064-7","article-title":"Prolonged remission in adult-onset Still's disease with etanercept","volume":"25","author":"Kumari","year":"2006","journal-title":"Clin Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2014.08.032_bb0710","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s10067-011-1735-0","article-title":"Is anti-TNF switching in refractory Still's disease safe and effective?","volume":"30","author":"Aikawa","year":"2011","journal-title":"Clin Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2014.08.032_bb0715","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1007\/s00296-011-2249-4","article-title":"Anakinra: a safe and effective first-line treatment in systemic onset juvenile idiopathic arthritis (SoJIA)","volume":"32","author":"Hedrich","year":"2012","journal-title":"Rheumatol Int"},{"issue":"6","key":"10.1016\/j.autrev.2014.08.032_bb0720","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/art.21061","article-title":"Rapid responses to anakinra in patients with refractory adult-onset Still's disease","volume":"52","author":"Fitzgerald","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2014.08.032_bb0725","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/acr.21901","article-title":"Anakinra in adult-onset Still's disease: long-term treatment in patients resistant to conventional therapy","volume":"65","author":"Giampietro","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.autrev.2014.08.032_bb0730","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3899\/jrheum.121098","article-title":"Higher-dose anakinra is effective in a case of medically refractory macrophage activation syndrome","volume":"40","author":"Kahn","year":"2013","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2014.08.032_bb0735","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/ard.2006.066381","article-title":"Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial","volume":"66","author":"Kalliolias","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.032_bb0740","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.semarthrit.2012.03.004","article-title":"The use of Canakinumab, a novel IL-1beta long-acting inhibitor, in refractory adult-onset Still's disease","volume":"42","author":"Kontzias","year":"2012","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.032_bb0745","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1111\/j.1756-185X.2010.01474.x","article-title":"A case of refractory adult-onset Still's disease treated with anakinra","volume":"13","author":"Lahiri","year":"2010","journal-title":"Int J Rheum Dis"},{"issue":"12","key":"10.1016\/j.autrev.2014.08.032_bb0750","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/imj.12002","article-title":"Successful treatment of macrophage activation syndrome complicating adult Still disease with anakinra","volume":"42","author":"Loh","year":"2012","journal-title":"Intern Med J"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.032_bb0755","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1136\/ard.2009.108068","article-title":"IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease","volume":"69","author":"Naumann","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.autrev.2014.08.032_bb0760","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1136\/annrheumdis-2012-201409","article-title":"IL-1 Trap rilonacept in refractory adult onset Still's disease","volume":"71","author":"Petryna","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.autrev.2014.08.032_bb0765","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/art.23437","article-title":"The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis","volume":"58","author":"Gattorno","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"25","key":"10.1016\/j.autrev.2014.08.032_bb0770","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1056\/NEJMoa1205099","article-title":"Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis","volume":"367","author":"Ruperto","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.032_bb0775","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/art.33342","article-title":"A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features","volume":"64","author":"Ruperto","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.032_bb0780","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.autrev.2012.07.026","article-title":"Targeting interleukin-1beta in CAPS (cryopyrin-associated periodic) syndromes: what did we learn?","volume":"12","author":"Kone-Paut","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.08.032_bb0785","doi-asserted-by":"crossref","DOI":"10.3109\/14397595.2014.899178","article-title":"Successful tocilizumab therapy in seven patients with refractory adult-onset Still's disease","author":"Bannai","year":"2014","journal-title":"Mod Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.032_bb0790","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ard.2008.088179","article-title":"Tocilizumab for multirefractory adult-onset Still's disease","volume":"68","author":"De Bandt","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.032_bb0795","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10067-012-2105-2","article-title":"Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence","volume":"32","author":"de Boysson","year":"2013","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.032_bb0800","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/1756-185X.12324","article-title":"A novel therapeutic approach in pulmonary arterial hypertension as a complication of adult-onset Still's disease: targeting IL-6","volume":"17","author":"Kadavath","year":"2014","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.032_bb0805","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/s10165-010-0365-8","article-title":"Successful tocilizumab treatment in a patient with adult-onset Still's disease complicated by chronic active hepatitis B and amyloid A amyloidosis","volume":"21","author":"Kishida","year":"2011","journal-title":"Mod Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2014.08.032_bb0810","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10067-009-1097-z","article-title":"Glucocorticoid and cyclosporine refractory adult onset Still's disease successfully treated with tocilizumab","volume":"28","author":"Matsumoto","year":"2009","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.032_bb0815","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/s10165-008-0116-2","article-title":"A case report of a patient with refractory adult-onset Still's disease who was successfully treated with tocilizumab over 6years","volume":"19","author":"Nakahara","year":"2009","journal-title":"Mod Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2014.08.032_bb0820","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s10067-010-1553-9","article-title":"A case of refractory adult-onset Still's disease successfully controlled with tocilizumab and a review of the literature","volume":"29","author":"Perdan-Pirkmajer","year":"2010","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.032_bb0825","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pharma.2012.03.001","article-title":"Adult refractory Still disease with atypical articular manifestations: efficacity of interleukin-6 antagonists (tocilizumab)","volume":"70","author":"Rkiouak","year":"2012","journal-title":"Ann Pharm Fr"},{"issue":"4","key":"10.1016\/j.autrev.2014.08.032_bb0830","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.semarthrit.2010.05.003","article-title":"Tocilizumab in refractory adult-onset Still's disease with aseptic meningitis\u2014efficacy of interleukin-6 blockade and review of the literature","volume":"40","author":"Sabnis","year":"2011","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2014.08.032_bb0835","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10067-011-1917-9","article-title":"Successful treatment of adult-onset Still's disease with tocilizumab monotherapy: two case reports and literature review","volume":"31","author":"Sakai","year":"2012","journal-title":"Clin Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2014.08.032_bb0840","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/rheumatology\/keu019","article-title":"Fulminant myocarditis and macrophage activation syndrome secondary to adult-onset Still's disease successfully treated with tocilizumab","volume":"53","author":"Savage","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.autrev.2014.08.032_bb0845","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s10067-010-1418-2","article-title":"Etanercept-refractory adult-onset Still's disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumab","volume":"29","author":"Sumida","year":"2010","journal-title":"Clin Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2014.08.032_bb0850","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1007\/s00296-010-1631-y","article-title":"Treatment of refractory adult-onset Still's disease with tocilizumab: report of two cases and review of the literature","volume":"31","author":"Thonhofer","year":"2011","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.032_bb0855","first-page":"141","article-title":"Successful treatment with tocilizumab in a patient with refractory adult-onset Still's disease (AOSD)","volume":"28","author":"Yoshimura","year":"2010","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.032_bb0860","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10067-013-2381-5","article-title":"Tocilizumab for the treatment of adult-onset Still's disease: results from a case series","volume":"33","author":"Cipriani","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2014.08.032_bb0865","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3899\/jrheum.130881","article-title":"Tocilizumab in adult-onset Still's disease: the Israeli experience","volume":"41","author":"Elkayam","year":"2014","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2014.08.032_bb0870","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/acr.20319","article-title":"Tocilizumab in refractory adult Still's disease","volume":"63","author":"Puechal","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10","key":"10.1016\/j.autrev.2014.08.032_bb0875","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1002\/art.23940","volume":"58","author":"Genovese","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"9617","key":"10.1016\/j.autrev.2014.08.032_bb0880","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(08)60453-5","article-title":"Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial","volume":"371","author":"Smolen","year":"2008","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.autrev.2014.08.032_bb0885","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","article-title":"Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis","volume":"367","author":"De Benedetti","year":"2012","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.autrev.2014.08.032_bb0890","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.3899\/jrheum.080150","article-title":"Blockade of interleukin 1 receptor in Still's disease affects activation of peripheral T-lymphocytes","volume":"35","author":"Youssef","year":"2008","journal-title":"J Rheumatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214001761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214001761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T07:01:20Z","timestamp":1746342080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997214001761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":178,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S1568997214001761"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2014.08.032","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adult onset Still's disease (AOSD) in the era of biologic therapies: Dichotomous view for cytokine and clinical expressions","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2014.08.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}